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Introduction
============

Extravasation of blood leukocytes is critical for immune surveillance and a crucial first step in the development of inflammation and atherosclerosis ([@bib35]; [@bib33]). Two well-characterized processes, selectin-mediated rolling and integrin-mediated firm adhesion, cooperate to promote accumulation of leukocytes on the luminal surface of the vascular endothelium ([@bib25]; [@bib35]). Subsequently, leukocytes actively migrate, in amoeboid fashion, across the endothelial monolayer into the interstitium, a process referred to as transendothelial migration (TEM) or diapedesis ([@bib25]; [@bib35]). A variety of adhesion molecules have been identified that are important for this process. These include on leukocytes the integrins leukocyte function-associated molecule-1 (LFA-1) (αLβ2), Mac-1 (αMβ2), and very late antigen-4 (VLA-4) (α4β1), and on endothelium the immunoglobulin superfamily members intercellular adhesion molecules 1 and 2 (ICAM-1 and ICAM-2), vascular cell adhesion molecule-1 (VCAM-1), platelet/endothelial cell adhesion molecule-1 (PECAM-1), and the junctional adhesion molecules, as well as the proline-rich glycoprotein CD99 ([@bib31]; [@bib25]; [@bib18]; [@bib29]; [@bib2]). However, the central issues of how the proper leukocyte directionality to cross the endothelium is established, and the nature of the route of transendothelial passage, remain unclear and controversial ([@bib22]; [@bib29]).

Shortly after arrest, most leukocytes spread and begin to migrate laterally over the apical surface of the endothelium ([@bib26]). At some point, usually within several minutes ([@bib26]), leukocytes make the critical "decision" to migrate in the direction perpendicular to the plane of the endothelium and extravasate. It has been suggested that shear forces provided by the luminal circulation may help to establish this directionality ([@bib9]), though robust diapedesis is also observed in many systems in the absence of shear. In addition, junctionally localized gradients of chemoattractants and adhesion molecules, such as PECAM-1, CD99, and the junctional adhesion molecules, have been proposed to direct leukocytes to endothelial junctions and to provide the requisite traction to drive diapedesis at these locations ([@bib5]; [@bib29], [@bib30]; [@bib2]). Furthermore, intra-endothelial cell signaling events are thought to facilitate leukocyte passage by transiently and locally down-regulating the integrity of the endothelial adherence junctions ([@bib20]; [@bib5]; [@bib1]; [@bib11]; [@bib2]; [@bib30]). Although all of these proposed mechanisms have merits, several considerations suggest that additional or alternate mechanism may also be important for physiologic extravasation.

First, the proposal that chemoattractants become preferentially distributed to endothelial junctions as a consequence of junctional "leakage" from the interstitium remains unsubstantiated. On the contrary, the studies to date that have carefully examined this issue in vivo, using transmission EM, demonstrate a distinct absence of junctional leakage of the chemokines IL-8 and RANTES ([@bib28]) or of EBV-induced molecule 1 ligand CC chemokine ([@bib3]), in postcapillary and high endothelial venules, respectively. Instead, these chemokines were shown to cross the endothelium via caveolar transcytosis, which resulted in selective presentation of chemokines on the apical microvilli ([@bib28]; [@bib3]). Moreover, although apically associated stromal cell--derived factor-1 (SDF-1) has been shown to be important for efficient lymphocyte diapedesis, a chemokine gradients per se was not required ([@bib9]).

Second, models involving junctionally localized adhesion molecules are predicated on physiologic leukocyte diapedesis occurring at endothelial cell--cell junctions, i.e., the paracellular route of TEM ([@bib5]; [@bib29], [@bib30]; [@bib2]). In the absence of conclusive observations made in the widely used in vitro cultured endothelial monolayer systems, the idea of nonjunctional TEM directly through individual endothelial cells, i.e., the transcellular route of TEM, has remained largely disregarded ([@bib22]; [@bib29]). However, some of the very first EM studies to address the nature of TEM in vivo provided evidence for the predominance of the transcellular route of diapedesis ([@bib38]; [@bib27]). Conclusive proof for transcellular migration in vivo has been provided by both serial-section transmission ([@bib27]; [@bib8]; [@bib17]; [@bib14], [@bib15]) and scanning ([@bib12]; [@bib8]; [@bib19]) EM studies. Clearly, such events should be independent of junctional chemoattractant and/or adhesion-molecule gradients and would not require mechanisms for separation of adherence junctions.

Proactive roles for the endothelium in facilitating diapedesis have been suggested by a variety of studies. For example, disruption of the cytoskeleton or blockade of intracellular calcium in the endothelium significantly reduces the rate and extent of leukocyte diapedesis without altering firm adhesion ([@bib20]; [@bib1]; [@bib11]; [@bib36]). Recently, we and others ([@bib4]; [@bib6]) have demonstrated that, as a consequence of binding to LFA-1 and VLA-4, respectively, the endothelium proactively generates ICAM-1-- and VCAM-1--enriched upright microvilli-like projections that surround a portion of the adherent leukocytes. However, in neither of these studies was any relationship between projections and leukocyte TEM characterized. Rather, in one of these, the projections were described explicitly as firm adhesion "docking structures" that were predicted to be inhibitory for diapedesis and thus speculated to undergo disassembly or disruption before diapedesis could proceed ([@bib4]). Alternatively, we directly demonstrated that inhibition of projection formation did not alter the strength of adhesion and, based on this and the kinetics of endothelial projection formation, hypothesized a role for these structures in leukocyte diapedesis ([@bib6]).

Here, we make extensive use of high resolution fluorescence imaging techniques to explore the route and mechanisms for diapedesis. We demonstrate unambiguously that leukocytes can use the transcellular route of diapedesis. Furthermore, both paracellular and transcellular TEM are associated with highly ICAM-1-- and VCAM-1--enriched endothelial projections which appear to play a role in guiding leukocyte extravasation.

Results
=======

Leukocytes transmigrate through both para- and transcellular routes
-------------------------------------------------------------------

To investigate the mechanism and route of leukocyte diapedesis, we established an in vitro system for imaging TEM of primary leukocytes. TNF-α--activated human umbilical vein endothelial cell (HUVEC) monolayers were treated with monocyte chemoattractant protein-1 (MCP-1) before addition of monocytes, with platelet activating factor (PAF) before addition of neutrophils, or with SDF-1 before addition of lymphocytes. Chemoattractant not associated with the monolayers was removed by washing and leukocytes were then incubated with the monolayers for various times followed by fixation and staining with antibodies to ICAM-1, LFA-1, and VE-cadherin, a specific marker for endothelial adherence junctions ([@bib23]). Samples were analyzed by high resolution, serial-sectioning confocal microscopy, coupled to digital deconvolution and three-dimensional image reconstruction, and leukocyte TEM was assessed according to the criteria described in Materials and methods.

At time periods of 10 min, significant numbers of all three classes of leukocytes were observed to be in the process of TEM. Remarkably, considerable fractions of TEM events were found to take place at sites clearly distinct from cell--cell junctions, demonstrating unambiguous use of the transcellular route of TEM ([Fig. 1](#fig1){ref-type="fig"}; Fig. S1, cell 2; Fig. S2, available at <http://www.jcb.org/cgi/content/full/jcb.200404129/DC1>). To analyze this statistically, at least 100 leukocytes in randomly selected fields from each of at least three separate experiments were imaged in all apical to basal planes. This revealed that 7 ± 1%, 5 ± 2%, and 11 ± 4% of the transmigrating monocytes, neutrophils, and lymphocytes, respectively, used transcellular routes. The remainder of leukocytes transmigrated at sites closely juxtaposed to endothelial cell--cell junctions, and were scored as paracellular TEM ([Fig. 2](#fig2){ref-type="fig"}; Fig. S1, cell 1; Fig. S2). Among the TEM events scored as paracellular, were many whose appearance was suggestive of a transcellular route, yet whose TEM passage was too close to endothelial cell--cell junctions for an unambiguous determination of transcellular TEM (Fig. S2 C).

![**Monocytes migrate across the endothelium via transcellular routes in association with ICAM-1 projections.** TNF-α--activated HUVECs were pretreated with MCP-1 and incubated with freshly isolated monocytes for 20 min. Cells were fixed and stained for ICAM-1 (CBRIC1/11-488; green), LFA-1 (CBR-LFA1/7-Cy3; red), and VE-cadherin (55-7H1-Cy5; blue; shown in A--D only) and imaged by confocal microscopy. (A) Top view projection of all z-series sections of a representative monocyte transmigrating via a transcellular route. (B--D) Field in A was rendered as a series of three-dimensional projections, each representing successive rotation about both the x and z axis in 30° intervals for a total of 90° about each axis. (E) Side view projection of cross section E in A depicting ICAM-1 projections (top) and linear LFA-1 clusters (bottom) separately. (F) Side view projection of cross section F in A. Apical (G), middle (H), or basal (I) z-axis sections, as indicated by brackets in F, are projected as top views. Bar, 5 μm.](200404129f1){#fig1}

![**Monocytes migrate across the endothelium via paracellular routes in association with ICAM-1 projections.** Samples were prepared as in [Fig. 1](#fig1){ref-type="fig"} with ICAM-1, LFA-1, and VE-cadherin (shown in A only) represented by green, red, and blue fluorescence, respectively. (A) Top view projection of all z-series sections of a representative monocyte transmigrating via a paracellular route. (B--D) Field in A was rendered as a series of three-dimensional projections, each representing successive rotation about both the x and z axis in 30° intervals for a total of 90° about each axis. (E) Side view projection of cross section of E in A depicting ICAM-1 projections (top) and linear LFA-1 clusters (bottom) separately. (F) Side view projection of cross section F in A. Apical (G), middle (H), or basal (I) z-axis sections, as indicated by brackets in F, are projected as top views. Bar, 5 μm.](200404129f2){#fig2}

The nature of the transcellular pore itself remains to be elucidated. However, as an initial step, we characterized the distribution of endothelial caveolin-1, a structural constituent of caveolea. These experiments demonstrate a partial, nonetheless unambiguous, association of caveolin-1 with the transcellular pore ([Fig. 3](#fig3){ref-type="fig"}), which is consistent with a potential relationship between caveolae and pore formation.

![**Caveolin-1 is partially associated with the transcellular migration pore.** Human lymphocytes were incubated for 10 min with TNF-α--activated, SDF-1--pretreated HUVECs transfected with either caveolin-1-GFP (A and B) or GFP-caveolin-1 (C and D) followed by fixation and staining. β2 (blue), ICAM-1 (IC1; red), and caveolin-1 (cav-1; green) are shown for representative transcellular migration events. Confocal sections that encompass the TEM passage ([Fig.1, F and H](#fig1){ref-type="fig"}) are projected as top views. Bar, 5 μm.](200404129f3){#fig3}

Leukocyte transmigration is highly associated with endothelial "cuplike" structures enriched in ICAM-1
------------------------------------------------------------------------------------------------------

The overall appearance of the endothelium and of the leukocytes was not significantly different among para- and transcellular TEM events and among monocytes, neutrophils, and lymphocytes ([Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}; Figs. S1 and S2). Most importantly, virtually all TEM events shared a previously unrecognized characteristic of being associated with upright microvilli-like ICAM-1--enriched endothelial projections that formed a cuplike structure that surrounded the site of diapedesis in a largely symmetrical fashion ([Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}; Figs. S1 and S2). This architecture was not altered when leukocytes were subjected to a wall shear stress of 4 dyne/cm^2^ in a laminar flow chamber during transmigration (Fig. S3, available at <http://www.jcb.org/cgi/content/full/jcb.200404129/DC1>).

Close investigation of leukocyte β2 integrin, the common subunit of the ICAM-1 receptors LFA-1 and Mac-1, revealed regions of increased density that formed linear clusters oriented parallel to the direction of diapedesis, which colocalized with the ICAM-1 projections ([Fig. 1](#fig1){ref-type="fig"} E; [Fig. 2](#fig2){ref-type="fig"} E; and [Fig. 6](#fig6){ref-type="fig"} C, bottom). Separate analysis of αL and αM subunits revealed similar results (unpublished data). As demonstrated previously ([@bib6]), leukocytes not associated with projections failed to exhibit linear integrin clusters (unpublished data).

To quantify the relationship between the cuplike structures and diapedesis, populations of leukocytes were scored using a system similar to one described previously ([@bib34]), as either adherent but not transmigrating (i.e., completely apical), in TEM stage-1 (TEM-1; ∼1--25% across the endothelium), TEM-2 (∼25--75% across the endothelium), TEM-3 (75--99% across the endothelium) or under the endothelium (100% below the endothelium). In addition, each cell was scored for the presence of significant ICAM-1--enriched projections of 1 μm in length or greater, and as transmigrating via either a para- or transcellular route.

Over a 60-min time course, the fraction of monocytes that had completed diapedesis steadily increased ([Fig. 4](#fig4){ref-type="fig"} A). At all time points the population of cells that were in any stage of TEM (TEM-1, -2, or -3) was highly associated with ICAM-1 projections (average projection-positive fraction was 96%). Consistent with our previous findings ([@bib6]), a proportion of cells on the apical surface of the endothelium that had not yet initiated diapedesis were also associated with ICAM-1 projections. However, the projection-positive fraction of these cells averaged only 41% (P value vs. transmigrating cells of \< 0.0001) over the 60-min time course. Using a single time point, a similar analysis was performed on neutrophils and lymphocytes ([Fig. 4](#fig4){ref-type="fig"} B), which demonstrated a nearly complete association of TEM events with ICAM-1 projections (neutrophils, 94%; lymphocytes, 98%) and a significantly lower percentage of adherent, nontransmigrating leukocytes associated with projections (neutrophils, 22% (P \< 0.0001); lymphocytes, 23% (P \< 0.0001)). This situation was similar under shear conditions (4 dyne/cm^2^), with the majority of transmigrating monocytes (94 ± 2%), neutrophils, (87 ± 6%) and lymphocytes (91 ± 2) associated with projections.

![**ICAM-1 projections are highly associated with transmigrating cells.** Monocytes (A) and neutrophils and lymphocytes (B) were incubated with TNF-α--activated and either MCP-1--, PAF-, or SDF-1--pretreated HUVEC monolayers, respectively, for the indicated number of minutes (m). Cells were fixed and stained for ICAM-1, LFA-1, and VE-cadherin. In each of three to eight separate experiments, a minimum of 100 leukocytes from randomly selected fields for each time point were carefully analyzed in all apical to basal planes and scored for the presence of ICAM-1--enriched projections of 1 μm in length or greater and as being either apically adherent (A), in the process of TEM (including both para- and transcellular events and including TEM stages 1--3) (T) or under (U) the HUVEC monolayer. Each bar represents the percentage of total cells scored at each indicated time point that were found in each of the three categories (i.e., A, T, or U). The black portion of each bar is the fraction of cells scored positive for associated ICAM-1 projections. The gray portion of each bar is the fraction of the cells that were negative for the presence of ICAM-1 projections. Values represent mean ± SEM (*n* = 3--8).](200404129f4){#fig4}

Of the ICAM-1 projection-positive population of transmigrating leukocytes, over all time points, 97% were associated with cuplike projections that were largely symmetrical, encircling at least 240° of the circumference of the leukocytes (See [Fig. 6](#fig6){ref-type="fig"}, A--C, bottom; Fig. S4, A--C, available at <http://www.jcb.org/cgi/content/full/jcb.200404129/DC1>). In contrast, of the projection-positive, apically adherent, nontransmigrating leukocytes, 30--50% were associated with asymmetrically distributed, "tetherlike" projections that contacted only one side of the leukocytes and were extended several, and sometimes up to 30 microns in length ([Fig. 5](#fig5){ref-type="fig"}). In these cases the leukocytes frequently exhibited polarized shapes suggestive of lateral migration ([@bib39]; [Fig. 5](#fig5){ref-type="fig"}). The attachment point on the leukocyte was typically one to several microns above the apical surface of the endothelium, and views parallel to the substrate ([Fig. 5](#fig5){ref-type="fig"} B, bottom) demonstrated that the projections spanned the distance between their endothelial origin and the leukocyte suspended above the endothelium. This architecture is roughly analogous to that described for selectin-mediated transient tethers formed under shear flow, with the distinction that tethers extended up from the endothelium to the reach leukocytes rather than down from the leukocyte to reach the substrate ([@bib7]). These findings strongly suggest that tetherlike projections were asymmetric as a result of lateral leukocyte migration away from their origin on the endothelium. To confirm this, live-cell time-lapse confocal microscopy was performed. This demonstrated that the distal ends of the projections were, indeed, attached to the trailing edge of the leukocytes and extended as a consequence of leukocyte lateral migration, whereas the endothelial origin of the projections remained stationary ([Fig. 5](#fig5){ref-type="fig"} C). Conversely, time-lapse showed that symmetric projections formed around leukocytes that were not migrating laterally (unpublished data).

![**Asymmetric projections are associated with laterally migrating cells.** Monocytes (A) and lymphocytes (B and C) were incubated with TNF-α--activated and either MCP-1-- or SDF-1--pretreated HUVEC monolayers, respectively. (A) After 10 min of incubation cells were fixed and stained for ICAM-1 (green) and LFA-1 (red). Four representative top view images depict apically adherent monocytes with asymmetrically distributed ICAM-1 projections. (B) Live-cell imaging of a representative laterally migrating SNARF-labeled lymphocyte (red) on the apical surface of the endothelium prelabeled with an anti--ICAM-1--Alexa 488 Fab fragment (green). Image depicts top (0°; top) and side (90°; bottom) views of a single ICAM-1--bearing cellular projection that is largely suspended above the apical surface of the endothelium and is attached to a lymphocyte migrating laterally to the right. (C) Live-cell time lapse imaging of another cell as in B. ICAM-1 projections emanating from the apical surface of the endothelium (arrowheads) attached to the trailing edge of a lymphocyte become elongated as the lymphocyte advances. Panels depict top view projections of confocal sections at 0, 2, and 4 min as indicated. Bars, 5 μm.](200404129f5){#fig5}

The endothelial cuplike structures are highly enriched in ICAM-1 and VCAM-1, but not ICAM-2, PECAM-1, or VE-cadherin
--------------------------------------------------------------------------------------------------------------------

To investigate the localization of other relevant endothelial adhesion molecules, ICAM-1 was visualized concomitantly with β2 integrin and either VCAM-1, ICAM-2, PECAM-1, or VE-cadherin. VCAM-1 was highly coenriched with ICAM-1 in the endothelial projections surrounding both adherent (not depicted) and transmigrating leukocytes ([Fig. 6, A and C](#fig6){ref-type="fig"}; Video 1, available at <http://www.jcb.org/cgi/content/full/jcb.200404129/DC1>). Conversely, VE-cadherin was localized to endothelial cell--cell junctions and was absent from projections ([Fig. 6](#fig6){ref-type="fig"} B and Fig. S4 C). Interestingly, although in the majority of the paracellular TEM events VE-cadherin staining was interrupted and absent at the site of diapedesis ([Fig. 7](#fig7){ref-type="fig"} B; Fig. S2, A and B; Fig. S4 C), in many cases the VE-cadherin was continuous and arched around one side of the TEM passage ([Fig. 2](#fig2){ref-type="fig"}, [6B](#fig6){ref-type="fig"}, Fig. S1, cell 1). ICAM-2 and PECAM-1 exhibited only modest localization to the endothelial projections (Fig. S4, A and B). Functional roles for these molecules in this context cannot be excluded.

![**ICAM-1 and VCAM-1, but not VE-cadherin, are highly enriched in projections surrounding sites of transmigration.** (A) Top view of 0.2-μm-thick confocal sections of a monocyte in TEM-1 at 0 μm (top) and 3 μm (bottom) above the apical surface of the endothelium. ICAM-1 (IC1, green), VCAM-1 (VC1, red), and β2 integrin (β2, blue) are shown either separately (left three) or merged (right). (B) Top view of confocal sections of a monocyte in TEM-1 at 0 μm (top) and 3 μm (bottom) above the apical endothelial surface. ICAM-1 (IC1, green), VE-cadherin (VE-CAD, red), and β2 integrin (β2, blue) are shown either separately (left three) or merged (right). Note that VE-cadherin staining at 0 μm is continuous at the TEM passage in contrast to Fig. S4 C. (C) Serial confocal sections of a monocyte in TEM-2 projected as top (0^o^, top) or side (90°, bottom) views. ICAM-1 (IC1, green), VCAM-1 (VC1, red), and β2 integrins (β2, blue) are shown either separately (left three) or merged (right). Three-dimensional rotation of these projections is shown in Video 1. (D) Serial confocal sections of a lymphocyte in TEM-2 projected as top (0^o^, left) or side (90°, right three) views. α4 integrin (α4, green) and VCAM-1 (VC1, red) are shown either separately (middle) or merged (left and right). Bars, 5 μm.](200404129f6){#fig6}

![**At early stages of TEM ICAM-1 projections encircle the endothelial migration passage.** Monocytes were incubated with TNF-α--activated, MCP-1--pretreated HUVECs for 10--20 min and then fixed and stained for ICAM-1 (IC1/11-488, green), LFA-1 (CBR-LFA1/7-Cy3, red), and VE-cadherin (55-7H1-Cy5, blue) and imaged by confocal microscopy. (A) All sections, the basal sections or the apical sections of a representative monocyte at an early stage of transcellular TEM-1. (B) A representative monocyte at a late stage of paracellular TEM-1. Dotted, dashed, and solid lines shown in the bottom panels indicate the edges of the sub-endothelial leukocyte membrane, the perimeter of the ICAM-1 projections and the TEM passage, respectively. Note that the TEM passage resides within the perimeter established by the ICAM-1 projections. Bars, 5 μm.](200404129f7){#fig7}

Given the strong enrichment of VCAM-1 to the projections, we also investigated the distribution of the leukocyte integrin VLA-4 (α4β1) on lymphocytes, the receptor for VCAM-1. These results revealed that α4, as with β2, αL and αM, was distributed to linear clusters on leukocytes that colocalized with the ICAM-1/VCAM-1--enriched endothelial projections ([Fig. 6](#fig6){ref-type="fig"} D).

At initial stages of TEM, ICAM-1 projections are clearly distinct from the TEM passage
--------------------------------------------------------------------------------------

Leukocytes at initial stages of TEM (TEM-1) looked much like adherent cells ([@bib6]) surrounded by a perimeter of vertical endothelial ICAM-1--enriched projections ([Fig. 6](#fig6){ref-type="fig"} A and [Fig. 7](#fig7){ref-type="fig"}; Fig. S1, cell 2 and Fig. S3, B and C). However, at the very bottom of the leukocyte/endothelial interface, usually at the center of the perimeter of ICAM-1 projections, was a small circular/ovoid gap (∼0.5-2 μm in diameter) completely devoid of ICAM-1 staining in all confocal sections (the TEM passage; [Fig. 6](#fig6){ref-type="fig"} A and [Fig. 7](#fig7){ref-type="fig"}; Fig. S1, cell 2 and Fig. S3, B and C). LFA-1 was clearly detected within the TEM passage extending down to the most basal sections indicating a portion of the leukocyte was spread underneath the endothelium. Thus, at initial stages of TEM the vertical endothelial projections are clearly distinct from the TEM passage itself and rather form a larger perimeter that encircles the location of passage formation, as though targeting this location for diapedesis. This feature was constant for both para- and transcellular routes of TEM and for monocytes ([Fig. 6](#fig6){ref-type="fig"} A and 7, Fig. S1, cell 2 and Fig. S3 B), neutrophils (Fig. S3 C) and lymphocytes (not depicted).

ICAM-1 projections remain associated with leukocytes through completion of diapedesis
-------------------------------------------------------------------------------------

At the late stages of TEM (TEM-3) the distal ends of the ICAM-1 projections remained well attached to the apical portion of the leukocytes with significant LFA-1 clustered underneath them (Fig. S5, A--C, available at <http://www.jcb.org/cgi/content/full/jcb.200404129/DC1>). At the very final stages or just after completion of TEM, the ICAM-1 projections remained attached to the LFA-1--enriched uropod of the subendothelial monocytes, neutrophils and lymphocytes. Thus, the ICAM-1 projections were often observed extending from the apical surface, through the nearly closed paracellular or transcellular TEM passage, into the basal/sub-endothelial space (Fig. S5, D--I), an assessment confirmed by parallel experiments using interference reflection microscopy (IRM; not depicted).

Conditions that attenuate formation of ICAM-1--enriched projections decrease TEM
--------------------------------------------------------------------------------

To assess the functional role of the ICAM-1--enriched projections in TEM, we scored the relative proportions of monocytes that were adherent, transmigrating or under the HUVEC monolayer after treatment with reagents (colchicine or 1,2Bis(2-aminophenoxy)ethane-*N*,*N*,*N*′,*N*′-tetraacetic acid tetrakis(acetoxymethyl ester); BAPTA-AM) shown previously to inhibit projections ([@bib6]). Compared with controls, colchicine and BAPTA-AM significantly reduced both para- and transcellular TEM (∼3-4-fold; [Fig. 8](#fig8){ref-type="fig"} A), which is consistent with previous studies ([@bib20]; [@bib11]; J. Greenwood and P. Adamson, personal communication). Whereas 50% of adherent cells had ICAM-1 projections on the control monolayers, only 16% and 18% of the adherent cells on colchicine and BAPTA-AM treated monolayers, respectively, were associated with projections ([Fig. 8](#fig8){ref-type="fig"} A). However, among the leukocytes that were in the process of TEM, the majority (96%, 91%, and 90% for control, colchicine, and BAPTA-AM--treated samples, respectively) were associated with ICAM-1 projections, regardless of HUVEC pretreatment ([Fig. 8](#fig8){ref-type="fig"} A).

![**Inhibition of ICAM-1 projections by BAPTA-AM, colchicine, or toxin-B is highly correlated with reduced TEM.** (A) TNF-α--activated, MCP-1--pretreated HUVECs were pretreated with vehicle (DMSO, 60 min), 10 μm colchicine (20 min), or 20 μm BAPTA-AM (60 min) washed and incubated with monocytes for 10 min at 37°C. Cells were fixed, stained for ICAM-1 (IC1/11-488), and LFA-1 (CBR-LFA1/7-Cy3) and then analyzed by confocal microscopy. In each of three to five separate experiments at least 100 monocytes in randomly selected fields were carefully analyzed in all apical to basal planes and scored for the presence of significant ICAM-1--enriched projections of 1 μm in length or greater and as being either apically adherent (A), in the process of TEM (including both para- and transcellular events and TEM 1--3) (T) or under (U) the HUVEC monolayer. Each bar represents the percentage of total cells scored for each experimental condition (DMSO, colchicine, or BAPTA-AM) in each of the three categories. The black portion of each bar is the fraction of cells positive for associated ICAM-1 projections. The gray portion of each bar is the fraction of the cells that were negative for the presence of ICAM-1 projections. (B) TNF-α--activated, SDF-1--pretreated HUVECs were pretreated with vehicle (PBS, 60 min, control), 100 ng/ml toxin-B (60 min) or 50 μg/ml C3 transferase (16 h) washed and then incubated with human lymphocytes for 10 min at 37°C. Samples were fixed, stained, and analyzed as in A. Values represent mean ± SEM (*n* = 3--5).](200404129f8){#fig8}

We demonstrated previously that the endothelial projections both were enriched in, and required, F-actin ([@bib6]). To assess the role of Rho family GTPases in projection formation, endothelial cells were pretreated with either *Clostridium diffucile* toxin-B, an inhibitor of Rho, Rac, and CDC42, or *Clostridium botulinum* C3 transferase, a selective inhibitor of Rho, under conditions that promoted similar deceases in actin stress fiber content, as assessed by phalloidin-FITC staining (unpublished data). For toxin-B this was associated with an approximately twofold reduction in both total projections and TEM ([Fig. 8](#fig8){ref-type="fig"} B), whereas, C3 had no effect on either projections, as shown previously ([@bib6]), or TEM in this setting ([Fig. 8](#fig8){ref-type="fig"} B). As above ([Fig. 8](#fig8){ref-type="fig"} A), in all cases the majority of TEM events (91%, 91%, and 93% for control, toxin-B, and C3-treated samples, respectively) were projection positive ([Fig. 8](#fig8){ref-type="fig"} B). These results imply a role for Rac and/or CDC42 in projection formation and provide correlative support for a functional role of projections in leukocyte diapedesis.

Discussion
==========

We have performed high resolution imaging of the distribution dynamics of the critical adhesion receptors for diapedesis in an in vitro transmigration system. These studies reveal unambiguous usage of a transcellular route, in addition to the paracellular route, for diapedesis by considerable fractions of primary monocytes, neutrophils, and lymphocytes. Independent of the route, TEM events were demonstrated for the first time to be highly associated with endothelial cuplike structures enriched in ICAM-1 and VCAM-1 that surrounded the sites of diapedesis. These endothelial structures appeared to organize leukocyte β2- and α4-containing integrins into discrete linear clustering patterns oriented parallel to the direction of diapedesis that colocalized with the ICAM-1 and VCAM-1 projections. Finally, conditions that disrupted endothelial projections correlated with a two- to fourfold reduction in TEM. The results suggest that the projections may function to facilitate and guide TEM by forming a cuplike traction structure that is aligned parallel to the direction of transmigration.

The route taken by blood leukocytes as they cross the endothelium is of critical mechanistic and regulatory importance. Pioneering work by A. Dvorak and H. Dvorak ([@bib14], [@bib15]) using serial-sectioning transmission EM provided unambiguous demonstration of the predominant use (at least in some settings) of the transcellular route of diapedesis in vivo. Similar observations have been made using serial-section transmission and/or scanning EM by others ([@bib27]; [@bib12]; [@bib8]; [@bib16]; [@bib17]; [@bib19]). Ironically, although in vivo scanning and serial-sectioning transmission EM have generally been accepted as proof for transcellular TEM, in vitro studies supporting paracellular TEM have apparently precluded general acceptance of this idea ([@bib22]; [@bib29]). Our in vitro findings here with three distinct types of primary leukocytes coupled with previous studies using in vivo models ([@bib27]; [@bib12]; [@bib8]; [@bib16]; [@bib17]; [@bib14], [@bib15]; [@bib19]) establish that a transcellular route for leukocyte diapedesis is likely to be an important and physiologically relevant phenomenon.

We suggest that our ability to detect transcellular TEM in this work is primarily a consequence of visualization of VE-cadherin (or PECAM-1) to discern junctions concomitantly with visualization of leukocyte integrins and their ligands on endothelium, to directly resolve the transendothelial passage. In addition, by using the highest resolution confocal imaging currently possible we were able to clearly visualize many transcellular TEM events that were in relatively close proximity to endothelial cell junctions ([Fig. 7](#fig7){ref-type="fig"} A; Fig. S2 C). Even so, in some cases apparent transcellular TEM passages were too close to cell junctions for an unambiguous determination of the route and these events were scored as paracellular. Thus, our assessment of transcellular TEM may be underestimated.

A critical aspect of transcellular TEM that remains to be elucidated is the nature of the membrane fusion events underlying formation of the transcellular passageway. Caveolae and the vesiculo-vacuolar organelle are two well-documented dynamic and interrelated vesicular structures found in endothelial cells that are thought to function in transcellular permeability to fluid and solutes ([@bib13]). These structures would seem ideal candidates for the membrane fusion elements required for pore formation in transcellular diapedesis ([@bib15]). Our studies here show that caveolin-1 exhibits a modest, though unambiguous, enrichment at the periphery of the transcellular passage supporting a possible function for caveolae in transcellular diapedesis. Given this, it is noteworthy that the relatively low percentages of transcellular diapedesis observed here in vitro, compared with some in vivo studies ([@bib15]), correlates with the relatively low levels of vesiculo-vacuolar organelle and caveolae in cultured endothelium compared with endothelium in vivo ([@bib37]).

We and others ([@bib4]; [@bib6]) have recently demonstrated that the endothelium proactively forms ICAM-1 and VCAM-1--enriched microvilli-like projections that form cuplike structures around populations of adherent leukocytes in an LFA-1-- and VLA-4-dependent manner. These studies did not address whether projections were associated with diapedesis. However, in one of them it was interpreted that the endothelial projection structures likely functioned in adhesion strengthening and were incompatible with diapedesis and therefore would be required to disassemble before diapedesis could proceed ([@bib4]).

To the contrary, based on both our previous ([@bib6]) and current studies, we conclude that any functional role attributed to the endothelial projections would most likely lie in transmigration. The kinetics of projection formation are on the order of minutes ([@bib6]), which is consistent with the time scale of diapedesis, but not with those of either rolling interactions (fractions of seconds) or firm adhesion (tens of seconds; [@bib26]). Moreover, our analysis here demonstrates that transmigrating leukocytes represent the predominant projection-associated leukocyte population with an essentially complete correlation between TEM and the presence of projections. Finally, disruption of endothelial projections failed to alter the strength of the adhesions formed ([@bib6]), but, as demonstrated here, correlated strongly with decreased efficiency of diapedesis. The finding that the subpopulations of projection-associated cells and transmigrating cells were essentially identical no matter whether monocytes, neutrophils, or lymphocytes were examined, or whether inhibitors were used, and that projections were highly associated with cells even at the very earliest detectable stages of TEM, suggests that projection formation is essential to the mechanism of diapedesis.

Based on this and the previously noted similarity to the phagocytic cup ([@bib4]), we propose the nomenclature "transmigratory cup" to describe this novel cell--cell interface architecture. Significantly, a variety of previous EM studies have made observations, including "endothelial microvilli" embracing transmigrating leukocytes, which is consistent with the formation of transmigratory cups in vivo ([@bib38]; [@bib12]; [@bib32]; [@bib16]).

We previously provided conclusive evidence that projection formation is the proactive response of the endothelium and does not require force or tension generation from the leukocyte ([@bib6]). However, based on our analysis of asymmetrically distributed projections found associated with the trailing edge of laterally migrating leukocytes, we conclude that forces generated by leukocytes can modify the endothelial projections. Because asymmetric lateral projections were associated only with laterally migrating cells, and TEM was associated only with symmetric, cuplike endothelial projections, diapedesis would seems to require a transition from a highly polarized phenotype and rapid lateral migration to greater symmetry (in the x-y plane) and reduced lateral migration.

As discussed above, an important issue for TEM is how leukocytes establish directionality during diapedesis. The current model is that junctionally localized chemoattractant and adhesion molecule gradients provide the principle driving force for this ([@bib5]; [@bib2]; [@bib30]). If we consider the transcellular migration events observed in this work, which occur at sites distant from endothelial junctions, we must conclude that an alternate "driving force" for TEM exists. The endothelial projections represent an attractive candidate for this. These vertical ICAM-1/VCAM-1--enriched microvilli-like projections form a cuplike traction structure that is aligned perpendicular to the plane of the endothelium and parallel to the direction of diapedesis, providing a physical basis for oriented migration. The finding that at sites opposing the endothelial projections, leukocyte integrins formed linear clusters reminiscent of fibrillar adhesions, on which cells are known exert forces during migration ([@bib10]), is consistent with this idea. Given that chemoattractants are well known to be critical for TEM ([@bib35]; [@bib9]; [@bib39]) we envision that they cooperate with the ICAM-1-- and VCAM-1--enriched transmigratory guidance structure in establishing proper directionality and, therefore, efficient TEM. In this regard, it is interesting to note that two prototypical chemokines, IL-8 and RANTES, have been shown to be distributed apically on endothelial microvilli in vivo ([@bib28]). Importantly, because the transmigratory cups were observed to be associated with virtually all TEM events, any functional consequences attributed to them should extend to both para- and transcellular TEM. In the case of paracellular TEM, projections would be anticipated to cooperate with other mechanisms previously shown to be functionally important ([@bib5]; [@bib2]; [@bib30]).

Our studies demonstrate that leukocytes use transcellular, in addition to paracellular, routes for diapedesis. Independent of route, TEM events were highly associated with the transmigratory cup, in which ICAM-1-- and VCAM-1--enriched vertical endothelial projections surround the site of leukocyte diapedesis. The architecture of this cup, and the high degree of correlation between these structures and the act of diapedesis, suggest that the transmigratory cup represents an important mode of directional guidance for TEM. The finding that both para- and transcellular TEM events by monocytes, neutrophils, and lymphocytes are associated with topologically similar transmigratory cups, demonstrates that this structure represents a general feature of TEM.

Materials and methods
=====================

Antibodies and reagents
-----------------------

Sources for antibodies to human αL (TS2/4), αM (CBRM1/23), β2 (CBR-LFA1/7), ICAM-1 (CBR-IC1/11), and ICAM-2 (CBR-IC2/1) have been described previously ([@bib21]; [@bib24]). Anti--CD14-FITC and control IgG2a-FITC were obtained from Immunotech. Anti--VE-cadherin (clone 55-7H1) and MCP-1 were obtained from BD Biosciences. Monoclonal anti-α4 (clone 7.2R) and anti--PECAM-1 (clone 9G11) and polyclonal anti--VCAM-1 and SDF-1 were obtained from R&D Systems. Fab fragments were prepared via papain cleavage according to the manufacturer\'s instructions (Pierce Chemical Co.). Antibody and Fab conjugation to Cy3, Cy5 (Amersham Biosciences), or Alexa 488 (Molecular Probes) bis-reactive dyes were according to manufacturer\'s instructions. PAF was obtained from Calbiochem. BAPTA-AM, colchicine, cytochalasin-[d]{.smallcaps}, and heparin were obtained from Sigma-Aldrich. Clostridium diffucile toxin-B was obtained from List Biochemicals. Clostridium botulinum C3 transferase was a gift provided by J. Greenwood and P. Adamson (University College of London, London, UK).

Cells and cell culture
----------------------

HUVECs, neutrophils, peripheral blood mononuclear cells, and monocytes were purified and cultured as described previously ([@bib6]). Lymphocytes were prepared by adsorbing the monocytes to gelatin-coated plates and culturing nonadherent lymphocytes in RPMI supplemented with 10% FBS and PHA (1 μg/ml) for 3 d, followed by culture in IL-2 (20 ng/ml) for 3--6 d. Flow cytometic analysis demonstrated that these cells were 97% CD3 positive. HUVEC transient transfection was performed by Amaxa nucleofection according to the manufacturer\'s instructions (Amaxa Inc.). DNA expression constructs for Caveolin-1-GFP and GFP-caveolin-1 were provided by M. Lisanti (Albert Einstein College of Medicine, Bronx, NY).

Adhesion and TEM experiments
----------------------------

For most fluorescence microscopy experiments, HUVECs were plated at 90% confluency on fibronectin (10 μg/ml)-coated polystyrene or glass surfaces and cultured for 48--72 h before use. HUVECs grown on gelatin or Matrigel gave results indistinguishable from those on fibronectin. Before each experiment, HUVECs were activated for 12 h with TNF-α (100 ng/ml). Immediately before addition of leukocytes, HUVECs were incubated with either PAF (100 nm), MCP-1 (200 ng/ml), or SDF-1 (200 ng/ml) at 37°C for 20 min. Where indicated, HUVECs were also preincubated with BAPTA-AM (20 μM, 1 h), colchicine (10 μM, 20 min), toxin-B (100 ng/ml, 1 h), C3 transferase (50 μg/ml, 16 h), or appropriate dilutions of vehicle (DMSO or PBS) concomitant with chemoattractant. In all cases, HUVECs were washed five times before addition of leukocytes with HBSS supplemented with 20 mM Hepes, pH 7.2, and 1% human serum albumin (buffer A). Freshly isolated neutrophils or monocytes or IL-2 cultured lymphocytes were washed and resuspended in buffer A and then added to HUVEC monolayers and incubated at 37°C for the indicated times. Cells were imaged live in Bioptechs chambers maintained at 37°C, or fixed in 3.7% formaldehyde in PBS for 5 min, stained for β2 (LFA1/7-Cy3 or -Cy5; 20 μg/ml), αL (TS2/4-Cy3; 20 μg/ml), αM (CBRM1/23-Cy3; 20 μg/ml), α4 (R7.2-488; 20 μg/ml), ICAM-1 (IC1/11-488, IC1/11-Fab-488, or IC1/11-Cy3; 20 μg/ml), ICAM-2 (IC2/1-488 or Cy3; 20 μg/ml), VCAM-1 (polyclonal anti--VCAM-1-Cy3; 20 μg/ml), PECAM-1 (9G11-Cy3), VE-cadherin (55-7H1-Cy3 or -Cy5; 20 μg/ml) in PBS for 20 min at RT and then washed three times with PBS before imaging. For live-cell experiments, endothelial cells were preincubated with nonfunction blocking IC1/11-Fab-488 (20 μg/ml) for 20 min and then washed before addition of leukocytes that were prelabeled with 5-(and-6)-chloromethyl SNARF-1, acetate (Molecular Probes) according to the manufacturer\'s instructions.

For shear experiments, HUVEC monolayers were assembled as the lower wall in a parallel-wall flow chamber in a 37°C warm room. Leukocytes, in buffer A, were infused at 0.3 dyne/cm^2^ for 30 s, to allow accumulation, then subjected to 4 dyne/cm^2^ shear force for 10 min and finally fixed by perfusion of buffer A/3.7% formaldehyde under the same shear. Cells were stained as above.

Image acquisition and processing
--------------------------------

Wide field differential interference contrast, IRM, and fluorescence imaging was conducted on an Axiovert S200 epifluorescence microscope (Carl Zeiss MicroImaging, Inc.), using a 63× oil objective, coupled to a Hamamatsu Orca CCD. Confocal imaging was performed with a Radiance 2000 Laser-scanning confocal system (Bio-Rad Laboratories) on a microscope (model BX50BWI; Olympus) with a 100× water immersion objective. For serial Z-stacks the section thickness was between 0.1 and 0.3 μm. Image processing, including background subtraction and digital deconvolution, was performed with Openlab software (Improvision). Three dimensional reconstruction and projection of Z-stacks was performed with VoxBlast software (Vay Tek). Images were then exported to Photoshop or Quicktime software for preparation of final images or videos, respectively.

Criteria for determination of leukocyte TEM
-------------------------------------------

Criteria for determination of leukocyte TEM were based on analysis of the relative distribution of ICAM-1, LFA-1, and VE-cadherin fluorescence in both the x-y and the z dimensions. The point of leukocyte penetration through the endothelium (the TEM passage) was defined by the region in the x-y dimension completely devoid of ICAM-1 fluorescence in all z-planes. The TEM passage contained leukocyte LFA-1 fluorescence that extended down to the most basal sections at the substrate. LFA-1 fluorescence adjacent to the TEM passage that was below that of ICAM-1 was taken to indicate portions of the leukocytes that had spread underneath the endothelium. The validity of our ICAM-1/LFA-1--based analysis of TEM was confirmed by parallel experiments that compared the localization of HUVEC stress fibers with leukocyte LFA-1 as described previously ([@bib34]). Further validation for our method came from IRM, which confirmed that portions of leukocytes determined by ICAM-1/LFA-1 fluorescence to have penetrated the endothelium were in close contact with the substrate, whereas the apical portions of the leukocytes were confirmed not to be in contact with the substrate. TEM adjacent to VE-cadherin-stained endothelial cell--cell junctions was scored as paracellular; TEM where no part of the TEM passage was within 1 μm of a junction was scored as transcellular.

Cells were scored as either adherent but not transmigrating, in TEM stage-1, -2, or -3 or under the endothelium. In addition, each cell was scored for the presence of significant ICAM-1--enriched vertical projections of 1 μm in length or greater. Projections associated with only one side of a leukocyte were termed "asymmetric" or "tetherlike", whereas those that were associated with at least 240° of the circumference of a leukocyte were termed "symmetric" or "cuplike".

Online supplemental material
----------------------------

Figs. S1--S3 show further examples of both para- and transcellular transmigratory cups with monocytes, neutrophils, and lymphocytes under static (1--2) and shear (3) conditions. Fig. S4 depicts distribution of ICAM-2, PECAM-1, and VE-cadherin relative to transmigratory cups. Fig. S5 shows ICAM-1 projections associated with sub-endothelial leukocytes. Video 1 shows three-dimensional rotation of the images depicted in [Fig. 6](#fig6){ref-type="fig"} C. Online supplemental materials are available at <http://www.jcb.org/cgi/content/full/jcb.200404129/DC1>.
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